Related Experiment Video
Updated: Jul 1, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Inhibition of BMP signaling pathway induced senescence and calcification in anaplastic meningioma
Kiyotaka Yokogami1, Takashi Watanabe2, Shinji Yamashita2
1Department of Neurosurgery, Faculty of Medicine, University of Miyazaki, Miyazaki, 889-1692, Japan. akatoyik@med.miyazaki-u.ac.jp.
Purpose:
Meningiomas are the most common type of brain tumors and are generally benign, but malignant atypical meningiomas and anaplastic meningiomas frequently recur with poor prognosis. The metabolism of meningiomas is little known, so few effective treatment options other than surgery and radiation are available, and the targets for treatment of recurrence are not well defined. The Aim of this paper is to find the therapeutic target.
Methods:
The effects of bone morphogenetic protein (BMP) signal inhibitor (K02288) and upstream regulator Gremlin2 (GREM2) on meningioma's growth and senescence were examined. In brief, we examined as follows: 1) Proliferation assay by inhibiting BMP signaling. 2) Comprehensive analysis of forced expression GREM2.3) Correlation between GREM2 mRNA expression and proliferation marker in 87 of our clinical samples. 4) Enrichment analysis between GREM2 high/low expressed groups using RNA-seq data (42 cases) from the public database GREIN. 5) Changes in metabolites and senescence markers associated with BMP signal suppression.
Results:
Inhibitors of BMP receptor (BMPR1A) and forced expression of GREM2 shifted tryptophan metabolism from kynurenine/quinolinic acid production to serotonin production in malignant meningiomas, reduced NAD + /NADH production, decreased gene cluster expression involved in oxidative phosphorylation, and caused decrease in ATP. Finally, malignant meningiomas underwent cellular senescence, decreased proliferation, and eventually formed psammoma bodies. Reanalyzed RNA-seq data of clinical samples obtained from GREIN showed that increased expression of GREM2 decreased the expression of genes involved in oxidative phosphorylation, similar to our experimental results.
Conclusions:
The GREM2-BMPR1A-tryptophan metabolic pathway in meningiomas is a potential new therapeutic target.
Insights
Targeting the GREM2-BMPR1A pathway in meningiomas offers a new therapeutic strategy. This approach modulates tryptophan metabolism, reduces energy production, and induces senescence in malignant brain tumors.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Metabolism
Background:
- Meningiomas are common brain tumors, often benign, but malignant subtypes recur with poor prognosis.
- Current treatments for recurrent meningiomas are limited, highlighting the need for novel therapeutic targets.
- Meningioma metabolism remains poorly understood, hindering the development of effective treatments.
Purpose of the Study:
- To identify a novel therapeutic target for recurrent and malignant meningiomas.
- To investigate the role of bone morphogenetic protein (BMP) signaling and Gremlin2 (GREM2) in meningioma progression.
- To elucidate the metabolic alterations in malignant meningiomas.
Main Methods:
- Examined the effects of a BMP signal inhibitor (K02288) and GREM2 on meningioma growth and senescence.
- Assessed proliferation by inhibiting BMP signaling and analyzed GREM2 overexpression.
- Correlated GREM2 mRNA expression with proliferation markers in clinical samples and analyzed RNA-seq data.
- Investigated metabolic and senescence marker changes following BMP signal suppression.
Main Results:
- Inhibiting BMP receptor (BMPR1A) and overexpressing GREM2 shifted tryptophan metabolism towards serotonin, reducing NAD+/NADH and ATP production.
- Decreased expression of genes involved in oxidative phosphorylation was observed in malignant meningiomas.
- Malignant meningiomas exhibited cellular senescence, reduced proliferation, and psammoma body formation.
- Analysis of clinical and public RNA-seq data confirmed that increased GREM2 expression correlates with reduced oxidative phosphorylation gene expression.
Conclusions:
- The GREM2-BMPR1A-tryptophan metabolic pathway represents a potential therapeutic target for meningiomas.
- Modulating this pathway may offer a new strategy for treating aggressive meningioma subtypes.
- Understanding meningioma metabolism is crucial for developing targeted therapies.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The JAK-STAT Signaling Pathway
Abnormal Proliferation
Inhibition of Cdk Activity

